1. Oelke M, Giuliano F, Simin KB, Thomas M, Angelina S et al: Treatment satisfaction with Tadalafil or Tamsulosin vs placebo in men with lower urinary tract symptoms (LUTS) suggestive of Benign Prosatic Hyperplasia (BPH): results from a randomized, placebo-controlled study. BJU Int. 2014; 114: 568-575.
2. Oelke M, Giuliano F, Mirone V, et al. Monotherapy with Tadalafil or Tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo- controlled clinical trial. Eur Urol 2012; 61: 917-925.
3. Hatzimouratidis K. A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction: Ther Adv Urol. 2014; 6: 135-147.
4. McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011; 185: 1793-1803.
5. Rosen R, Altwein J, Boyle P, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003;44: 637-649.
6. Rosen RC, et al. Development and evaluation of an abridged, 5 item versión of the International Index of Erectile Function (IIEF) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11: 319-326.
Comentarios
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.